Sumitomo Pharma (4506) Stock Overview
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
4506 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Sumitomo Pharma Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,609.50 |
| 52 Week High | JP¥3,288.00 |
| 52 Week Low | JP¥1,188.00 |
| Beta | 0.48 |
| 1 Month Change | 14.03% |
| 3 Month Change | 11.62% |
| 1 Year Change | -3.74% |
| 3 Year Change | 206.75% |
| 5 Year Change | -20.68% |
| Change since IPO | 5.62% |
Recent News & Updates
4506: Index Inclusion And Leukemia Pipeline Will Support Future Upside
Analysts now place Sumitomo Pharma's fair value at approximately ¥2,071, up from ¥2,000. The updated target reflects revised assumptions for the discount rate, revenue growth, profit margin and future P/E.Sumitomo Pharma's (TSE:4506) Attractive Earnings Are Not All Good News For Shareholders
We didn't see Sumitomo Pharma Co., Ltd.'s ( TSE:4506 ) stock surge when it reported robust earnings recently. We looked...Recent updates
4506: Index Inclusion And Leukemia Pipeline Will Support Future Upside
Analysts now place Sumitomo Pharma's fair value at approximately ¥2,071, up from ¥2,000. The updated target reflects revised assumptions for the discount rate, revenue growth, profit margin and future P/E.Sumitomo Pharma's (TSE:4506) Attractive Earnings Are Not All Good News For Shareholders
We didn't see Sumitomo Pharma Co., Ltd.'s ( TSE:4506 ) stock surge when it reported robust earnings recently. We looked...4506: Orphan Drug Designations Will Support Future Leukemia Pipeline Upside
Analysts now place Sumitomo Pharma's fair value estimate at ¥2,000, down from ¥2,158. The adjustment reflects updated views on revenue growth, profit margins, and the appropriate discount rate and P/E multiple for the stock.Investors Shouldn't Be Too Comfortable With Sumitomo Pharma's (TSE:4506) Earnings
Sumitomo Pharma Co., Ltd.'s ( TSE:4506 ) robust earnings report didn't manage to move the market for its stock. Our...Optimistic Investors Push Sumitomo Pharma Co., Ltd. (TSE:4506) Shares Up 26% But Growth Is Lacking
Despite an already strong run, Sumitomo Pharma Co., Ltd. ( TSE:4506 ) shares have been powering on, with a gain of 26...Is Sumitomo Pharma (TSE:4506) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Investors Appear Satisfied With Sumitomo Pharma Co., Ltd.'s (TSE:4506) Prospects As Shares Rocket 38%
Despite an already strong run, Sumitomo Pharma Co., Ltd. ( TSE:4506 ) shares have been powering on, with a gain of 38...Results: Sumitomo Pharma Co., Ltd. Beat Earnings Expectations And Analysts Now Have New Forecasts
A week ago, Sumitomo Pharma Co., Ltd. ( TSE:4506 ) came out with a strong set of first-quarter numbers that could...Sumitomo Pharma Co., Ltd.'s (TSE:4506) Shares Climb 36% But Its Business Is Yet to Catch Up
Sumitomo Pharma Co., Ltd. ( TSE:4506 ) shares have continued their recent momentum with a 36% gain in the last month...Does Sumitomo Pharma (TSE:4506) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Sumitomo Pharma Co., Ltd.'s (TSE:4506) 30% Share Price Surge Not Quite Adding Up
Sumitomo Pharma Co., Ltd. ( TSE:4506 ) shares have continued their recent momentum with a 30% gain in the last month...We Believe Sumitomo Pharma's (TSE:4506) Earnings Are A Poor Guide For Its Profitability
Strong earnings weren't enough to please Sumitomo Pharma Co., Ltd.'s ( TSE:4506 ) shareholders over the last week. We...Sumitomo Pharma Co., Ltd. Just Recorded A 72% EPS Beat: Here's What Analysts Are Forecasting Next
A week ago, Sumitomo Pharma Co., Ltd. ( TSE:4506 ) came out with a strong set of full-year numbers that could...Why Investors Shouldn't Be Surprised By Sumitomo Pharma Co., Ltd.'s (TSE:4506) 26% Share Price Plunge
Sumitomo Pharma Co., Ltd. ( TSE:4506 ) shares have had a horrible month, losing 26% after a relatively good period...Is Sumitomo Pharma (TSE:4506) Using Debt In A Risky Way?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Sumitomo Pharma Co., Ltd. Just Recorded A 593% EPS Beat: Here's What Analysts Are Forecasting Next
Sumitomo Pharma Co., Ltd. ( TSE:4506 ) just released its quarterly report and things are looking bullish. Statutory...Sentiment Still Eluding Sumitomo Pharma Co., Ltd. (TSE:4506)
You may think that with a price-to-sales (or "P/S") ratio of 0.6x Sumitomo Pharma Co., Ltd. ( TSE:4506 ) is a stock...Sumitomo Pharma (TSE:4506) Has Debt But No Earnings; Should You Worry?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Is There An Opportunity With Sumitomo Pharma Co., Ltd.'s (TSE:4506) 38% Undervaluation?
Key Insights The projected fair value for Sumitomo Pharma is JP¥909 based on 2 Stage Free Cash Flow to Equity Current...There's No Escaping Sumitomo Pharma Co., Ltd.'s (TSE:4506) Muted Revenues Despite A 26% Share Price Rise
Sumitomo Pharma Co., Ltd. ( TSE:4506 ) shares have continued their recent momentum with a 26% gain in the last month...A Piece Of The Puzzle Missing From Sumitomo Pharma Co., Ltd.'s (TSE:4506) 28% Share Price Climb
Those holding Sumitomo Pharma Co., Ltd. ( TSE:4506 ) shares would be relieved that the share price has rebounded 28% in...Is Sumitomo Pharma Co., Ltd. (TSE:4506) Trading At A 34% Discount?
Key Insights Sumitomo Pharma's estimated fair value is JP¥628 based on 2 Stage Free Cash Flow to Equity Sumitomo Pharma...Market Cool On Sumitomo Pharma Co., Ltd.'s (TSE:4506) Revenues
You may think that with a price-to-sales (or "P/S") ratio of 0.5x Sumitomo Pharma Co., Ltd. ( TSE:4506 ) is a stock...Shareholder Returns
| 4506 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | 1.7% | 4.2% | 1.5% |
| 1Y | -3.7% | 10.8% | 29.1% |
Return vs Industry: 4506 underperformed the JP Pharmaceuticals industry which returned 10.8% over the past year.
Return vs Market: 4506 underperformed the JP Market which returned 29.1% over the past year.
Price Volatility
| 4506 volatility | |
|---|---|
| 4506 Average Weekly Movement | 6.2% |
| Pharmaceuticals Industry Average Movement | 4.1% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 8.5% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4506's share price has been volatile over the past 3 months compared to the JP market.
Volatility Over Time: 4506's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1897 | n/a | Toru Kimura | www.sumitomo-pharma.com |
Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson’s disease, type 2 diabetes, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic.
Sumitomo Pharma Co., Ltd. Fundamentals Summary
| 4506 fundamental statistics | |
|---|---|
| Market cap | JP¥722.01b |
| Earnings (TTM) | JP¥112.66b |
| Revenue (TTM) | JP¥474.79b |
Is 4506 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4506 income statement (TTM) | |
|---|---|
| Revenue | JP¥474.79b |
| Cost of Revenue | JP¥213.70b |
| Gross Profit | JP¥261.08b |
| Other Expenses | JP¥148.43b |
| Earnings | JP¥112.66b |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
Oct 30, 2026
| Earnings per share (EPS) | 251.13 |
| Gross Margin | 54.99% |
| Net Profit Margin | 23.73% |
| Debt/Equity Ratio | 39.3% |
How did 4506 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/22 00:22 |
| End of Day Share Price | 2026/09/18 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sumitomo Pharma Co., Ltd. is covered by 17 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Atsushi Seki | Barclays |
| Koichi Mamegano | BofA Global Research |
| Hidemaru Yamaguchi | Citigroup Inc |